North American hyaluronic acid-based dermal fillers market Size, Share, Trends &Posted by Avinash on February 13th, 2020 The North American hyaluronic acid-based dermal fillers market is estimated to grow at a CAGR of 7.3% during the forecast period. The North American market is expected to reach around .4 billion in 2025 as compared to nearly .4 billion in 2018. Growing minimally invasive procedures has increased the number of cosmetic procedures in the region as the minimally invasive procedure provides faster recovery and better cosmetic results which are contributing to the market growth. Other crucial factors are promoting market growth in the region. This includes a significant rise in the population with the age group, ranging between 18 and 64. For instance, as per the US Census Bureau, in 2017, the total population in the US was 325.7 million, of which 62% was constituted by 18-64 age group people. This, in turn, is contributing to the demand for advanced dermal fillers in the region coupled with increasing consciousness about physical appearance. Request a Free Sample of our Report on France Cardiac Biomarker Market: https://www.omrglobal.com/request-sample/north-american-hyaluronic-acid-based-dermal-fillers-market The main objective of dermal filler is to replace the lost volume that causes the cheeks to flatten, marionette lines to form and develop nasolabial folds. The procedure is intended to correct this loss of volume in a natural, subtle way and restore volume to the face. To improve the efficiency of the treatment, the US FDA has approved multiple dermal fillers which are produced from temporary or absorbable material for the correction of moderate to severe facial wrinkles and skin folds, including nasolabial folds. It has approved dermal filler produced from non-absorbable (permanent) material only for the correction of cheek acne scars and nasolabial folds in patients more than the age of 21 years. The North American hyaluronic acid-based dermal fillers market is segmented based on application and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on end-user, the market is segmented into dermatology clinics and hospitals. A full Report of France Cardiac Biomarker Market is Available at: Key players operating in the North American hyaluronic acid-based dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market. For instance, in November 2018, Galderma Laboratories, L.P. received an FDA approval for ‘Restylane Lyft’, a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies. Market Segmentation North American Hyaluronic Acid-Based Dermal Fillers Market by Application
North American Hyaluronic Acid-Based Dermal Fillers Market by End-User
Regional Analysis
Company Profiles
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |